Recent praise from our clients

Posted:
1
July 2003

This is a selection of comments received over the last six months from our clients.

“I’m currently commissioning articles for the clinical trials section in the next issue, and my attention was drawn to the innovative approach that Richmond Pharmacology takes to designing & implementing studies.”“Generally, the draft study report looks very good. Well done!”“

Indeed it was the excellent job that you, Radi and the rest of the team did that prompted me to search you out again.”“…thanks for sending this excellent and comprehensive report that must have been a lot of work to prepare and compile.”“thank you very much for the data. I would like to wish you a Merry Christmas and a Happy New Year and I must say that for me it has been a pleasure working with you this year.”“I received the human plasma and am very impressed with the service provided by Richmond. I will be placing further orders of human plasma with you during the year.”“…I forgot to tell you that the SQN people had high praise for the quality of Richmond’s Case Report Forms; they said that they are the cleanest CRFs received from any of the companies they work with.”“

I would like to congratulate you on the successful completion of the clinical work for the two studies that you recently conducted, and apologise that this letter is rather late! I would particularly like to thank you for the time and effort that you put in to perfecting the Peripheral Blood Monocyte Concentration sampling procedures, I was very pleased that when it came to the ‘live’ runs everything went so smoothly.

On this study I think that you exceeded our expectations, although, of course, not mine; I always knew that you would do well! It was a great pleasure monitoring your unit, everyone made me feel very welcome and the work was a consistently high level. In fact there were some days I began to wonder if I was monitoring properly as there were so few queries! Please can you pass on my thanks and appreciation to the entire Richmond Pharmacology team for their work on these two studies.”“We are very pleased that we were able to complete these studies on time and to the high standards required. The Richmond team has worked hard to meet the timelines and we appreciate that very much.”

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more